Verona Pharma plc (NASDAQ:VRNA)’s shares experienced a boost in July when pharmaceutical giant Merck announced that it would ...

Private equity work is up year-over-year, but tariffs, inflation and valuations continue to be an issue for dealmakers.

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 7,175 calls trading, 1.0x expected, and implied vol increasing almost 2 ...